Fortress Biotech Ownership | Who Owns Fortress Biotech?
Fortress Biotech Ownership Summary
Fortress Biotech is owned by 16.79% institutional investors, 21.11% insiders, and 62.11% retail investors. Gsa capital partners llp is the largest institutional shareholder, holding 0% of FBIO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.02% of its assets in Fortress Biotech shares.
FBIO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Fortress Biotech | 16.79% | 21.11% | 62.11% |
| Sector | Healthcare Stocks | 279.42% | 10.64% | -190.05% |
| Industry | Biotech Stocks | 64.05% | 10.69% | 25.27% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Gsa capital partners llp | - | - | - |
| Tower research capital llc (trc) | - | - | - |
| Jane street group | - | - | - |
| Meridian wealth management | - | - | - |
| Cambridge investment research advisors | - | - | - |
| Hb wealth management | - | - | - |
| Xtx topco | - | - | - |
| B. riley wealth advisors | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Gsa capital partners llp | - | - | - |
| Tower research capital llc (trc) | - | - | - |
| Jane street group | - | - | - |
| Meridian wealth management | - | - | - |
| Cambridge investment research advisors | - | - | - |
| Hb wealth management | - | - | - |
| Xtx topco | - | - | - |
| B. riley wealth advisors | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tower research capital llc (trc) | - | - | -1.97K |
| Meridian wealth management | - | - | -10.00K |
| Xtx topco | - | - | -30.62K |
| Jane street group | - | - | -34.16K |
| Gsa capital partners llp | - | - | -60.47K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Cambridge investment research advisors | - | - | -1.00M |
| B. riley wealth advisors | - | - | -144.70K |
| Hb wealth management | - | - | -113.35K |
| Gsa capital partners llp | - | - | -60.47K |
| Jane street group | - | - | -34.16K |
Sold Out
| Holder | Change |
|---|---|
| Tower research capital llc (trc) | -1.97K |
| Meridian wealth management | -10.00K |
| Xtx topco | -30.62K |
| Jane street group | -34.16K |
| Gsa capital partners llp | -60.47K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 48 | -12.73% | 4,440,118 | -7.34% | 16 | 3.16% | 20 | -39.39% | 12 | 9.09% |
| Dec 31, 2024 | 55 | 3.77% | 4,791,948 | 7.76% | 23 | 4.52% | 33 | 32.00% | 11 | -15.38% |
| Sep 30, 2024 | 53 | -1.85% | 4,447,052 | 22.70% | 22 | 5.77% | 25 | -7.41% | 13 | 8.33% |
| Jun 30, 2024 | 54 | 22.73% | 3,624,236 | 23.64% | 19 | 6.77% | 27 | 17.39% | 12 | 20.00% |
| Mar 31, 2024 | 1 | - | 144,700 | - | - | - | 1 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 598.04K | 2.02% | - |
| Vanguard US Total Market Shares ETF | 470.54K | 1.59% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 252.84K | 0.86% | - |
| Fidelity Extended Market Index | 112.86K | 0.38% | -295.00 |
| iShares Micro-Cap ETF | 52.60K | 0.18% | - |
| Fidelity Total Market Index | 49.88K | 0.17% | - |
| NT Ext Equity Mkt Idx Fd - NL | 45.89K | 0.16% | 28.57K |
| NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 35.63K | 0.12% | 22.15K |
| Fidelity Series Total Market Index | 29.00K | 0.10% | - |
| Spartan Extended Market Index Pool F | 24.47K | 0.08% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 23, 2024 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | Buy | $1.40M |
| Sep 23, 2024 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | Buy | $1.40M |
| Jul 11, 2024 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | Buy | $37.42K |
| Jul 10, 2024 | Jin David | Chief Financial Officer | Buy | $3.75K |
| Jul 09, 2024 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | Buy | $36.97K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q3 | 6 | - |
| 2024 Q2 | 2 | 1 |
FBIO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools